NewsRoom Articles - Page 180 of 219

FridayFeb 19, 2021 11:35 am

Ryah Group Inc. Making Digital Transformation in the Lab a Reality

Company has completed steps necessary to achieve, sustain competitive advantage in move towards remote-health solutions and trials RYAH technology optimizes patient feedback so medical trials, studies can move into remote solution zones Recently developed an integrated, customized mobile application to support a major clinical study in the United Kingdom RYAH created cloud of stored data to help with R&D of future medical treatments RYAH Group, a leading digital health-care analytics and technology company, is on a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. The company believes that, when patients are given more…

ThursdayFeb 18, 2021 2:30 pm

Research Discovers Wearable Devices Can Detect the Coronavirus

Results from various studies conducted by leading research institutions in the Unites States have found that wearables such as smartwatches, which measure an individual’s heart rate, also possess the ability to identify whether a person is coronavirus positive — even before symptoms start showing or the virus is detected using a test. These results, which were announced from institutions including Stanford University, California and New York’s Mount Sinai Health System, demonstrate that these devices detect the virus’s presence by measuring the pulse of a person’s heartbeat and their skin temperature as well as other biometric and physiological features. Some of…

ThursdayFeb 18, 2021 9:43 am

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Improving the Odds in Fighting Bladder Cancers

Imagin Medical Inc. is a surgical imaging company helping to advance the use of blue light cystoscopy (“BLC”) in battling bladder cancer and reducing costs associated with these procedures Bladder cancer is the sixth most prevalent cancer in the United States, and the third most common in men, yet the most expensive to treat While early-stage cancer intervention involves illuminating the bladder with white light – the light that can be seen by the human eye - to visualize and resect tumors, historical use of white light has resulted in incomplete tumor removal and a greater than 50% recurrence rate…

ThursdayFeb 18, 2021 9:22 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation of Medicines with Potential to Treat Rising Mental Health Challenges from Depression

Mental health experts note growing concern over impact of COVID-19 on nation’s mental health Compounding stress could have serious health, social consequences VTGN offers new hope to those dealing with depression disorders A new survey from the American Psychological Association (“APA”) shines a spotlight on the growing concern about the impact of the global pandemic on the nation’s mental health (https://ibn.fm/ukaIx). These rising numbers, as well as the treatment for mental health illness and disorders, is of great concern to VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medications that goes beyond the standard of…

WednesdayFeb 17, 2021 2:00 pm

Berkshire Biomedical Secures $3M in Funding for Development of Virtual Biometric Health Care System

Berkshire Biomedical, a medical equipment manufacturer based in Dallas, announced that it had acquired third-party funding totaling $3 million, which the company will use to advance the development of its prescription-drug and virtual-care management system. The system uses dual biometric authentication, which includes dental recognition. The biometric system is currently not available for commercial use but will be used to curb nonadherence to medication. The company states that medication nonadherence causes roughly 125,000 deaths in America each year and makes up nearly 10% of hospitalizations. The system’s main product is COPA, a computerized oral prescription administrator. COPA will help improve…

WednesdayFeb 17, 2021 1:45 pm

New Imaging Test to Help Doctors Predict Cancer Patients Who Can Benefit from Hormone Therapy

Women who have cancer cells carrying estrogen receptors are usually given hormonal therapy as a targeted treatment. However, this treatment is not effective in all patients. However, a good method of accurately predicting which patients will benefit from the treatment and which will not hasn’t existed — until now. Enter a study conducted by researchers from the Washington University School of Medicine, St. Louis. The researchers have found that they can differentiate between patients who may or may not benefit from hormone therapy through the use of an imaging test that measures the estrogen receptor function in the patients’ cancer…

TuesdayFeb 16, 2021 3:27 pm

United Medical Equipment Business Solutions Network Inc. Stands Ready to Address Swelling Market Need

Frequent, COVID-19 rapid tests could spur end of pandemic, make stay-at-home orders possible Countries turning to faster, more affordable tests to curb virus spread, enable economic recovery United Medical poised to capitalize on surging demand for rapid testing Frequent rapid testing could curb COVID-19 within weeks, a recent study published by the University of Colorado Boulder and Harvard University shows (https://ibn.fm/qmy42). Factors such as test turnaround-time and frequency are key in limiting the spread of the virus, making rapid tests one of the key tools for managing the virus outbreak. As such, the rapid tests are increasingly used in countries…

TuesdayFeb 16, 2021 2:30 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Outlines 2021 Business Strategies for COVID-19 PCR Testing and Psychedelic Treatments

XPhyto Therapeutics Corp. plans to commercialize its rapid and portable PCR Kit this year to provide point-of-care diagnostics The company is confident about the successful validation of the PCR kit for the European commercial (CE-IVD) approval in Q1 2021 Hugh Rogers, CEO and Director of XPhyto, revealed in the latest news release that the company will make investments and development of psychedelic treatments XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator involved in the development of new pharmaceuticals, diagnostic products, and psychedelic medicine. As a part of its business strategy for the year 2021, the company…

TuesdayFeb 16, 2021 11:37 am

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Plant-Based Biopesticide Achieves 100% Control of Root-Rot Disease in Recent Studies

Most recent tests show MustGrow’s patented biopesticide achieved 100% control over Aphanomyces within 24 hours Plant-based biopesticide uses natural defense mechanism found in mustard seed to control diseases, pests and weeds MustGrow hoping to provide valuable crop-protection tool for pulse-crop farmers MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has announced that its plant-based biopesticide has achieved 100% control of root-rot disease in a recent round of laboratory tests (https://ibn.fm/dmGPy). MustGrow, an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops such as fruits and vegetables, is focused on providing natural, science-based biological solutions to replace synthetic…

FridayFeb 12, 2021 3:21 pm

CNS Pharmaceuticals (NASDAQ: CNSP) Celebrates IND Status, Prepares to Launch Brain Cancer Drug Trials

Brain cancer drug developer CNS Pharmaceuticals is celebrating recent news that the U.S. Food and Drug Administration (“FDA”) granted investigational new drug (“IND”) status to CNS Pharmaceuticals’ leading candidate for fighting glioblastomas Glioblastomas are a class of aggressive brain cancers with no known cure and a median life expectancy of 14 to 16 months following diagnosis The FDA’s decision to grant CNSP’s request for IND status clears the way for the company to begin human clinical trials within the next couple of months The company’s sublicensee partner, WPD Pharmaceuticals, will also prepare a first-ever Phase I trial for drug safety…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Ryah Group Inc. Making Digital Transformation in the Lab a Reality

Research Discovers Wearable Devices Can Detect the Coronavirus

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Improving the Odds in Fighting Bladder Cancers

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation of Medicines with Potential to Treat Rising Mental Health Challenges from Depression

Berkshire Biomedical Secures $3M in Funding for Development of Virtual Biometric Health Care System

New Imaging Test to Help Doctors Predict Cancer Patients Who Can Benefit from Hormone Therapy

United Medical Equipment Business Solutions Network Inc. Stands Ready to Address Swelling Market Need

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Outlines 2021 Business Strategies for COVID-19 PCR Testing and Psychedelic Treatments

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Plant-Based Biopesticide Achieves 100% Control of Root-Rot Disease in Recent Studies

CNS Pharmaceuticals (NASDAQ: CNSP) Celebrates IND Status, Prepares to Launch Brain Cancer Drug Trials

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search